decorative header image

Viability Assay

Experience our cardiac viability assay designed to evaluate cellular changes triggered by compounds or immune cell-induced structural toxicity within a high-throughput 96-well system.

Utilizing electrical impedance sensing, our cutting-edge CardioExcyte 96 module offers real-time insights into cell and monolayer integrity changes. This innovative technology enables the monitoring of acute and chronic cell activity of cardiomyocytes and other cell types, providing a dynamic measure of cellular responses over time to evaluate:

  • Cell Adhesion and Proliferation
  • Cell Monitoring
  • Cytotoxicity
  • CAR-T induced Cellular Effects

Access a thorough assessment of cellular changes with this comprehensive approach by merging cellular dynamics analysis with simultaneous precise MEA-like Electric Field Potential (EFP) recordings.

Our expert team collaborates closely with each client to custom-design every service, ensuring tailored solutions that meet specific research needs. We conduct rapid and comprehensive analyses of impedance recordings. Within a streamlined process, these analyses consolidate in a detailed end-to-end study report delivered in less than six weeks.

Viability Study Timeline

Contact us to accelerate your research today!

Get in touch

The CiPA consortium has rigorously validated and applied impedance-based methodology to evaluate compound-induced changes in cellular behavior within human-based cell models. Hence, this CardioExcyte 96-based cardiac viability service facilitates valuable preclinical risk assessments.

For additional information download our

Cardiac Viability Flyer